Swiss National Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47M Sell
546,000
-35,700
-6% -$3.13M 0.02% 462
2026
Q1
$52.6M Buy
581,700
+38,800
+7% +$3.56M 0.03% 427
2025
Q4
$48.8M Sell
542,900
-27,300
-5% -$2.59M 0.03% 432
2025
Q3
$56.2M Sell
570,200
-29,000
-5% -$2.87M 0.03% 402
2025
Q2
$54.7M Buy
599,200
+37,700
+7% +$3.65M 0.03% 416
2025
Q1
$63.6M Sell
561,500
-13,800
-2% -$1.48M 0.04% 348
2024
Q4
$60.8M Sell
575,300
-35,400
-6% -$3.8M 0.04% 365
2024
Q3
$65.9M Buy
610,700
+3,500
+0.6% +$382K 0.04% 355
2024
Q2
$65.9M Sell
607,200
-18,600
-3% -$2.19M 0.05% 340
2024
Q1
$82.6M Sell
625,800
-27,700
-4% -$3.46M 0.06% 300
2023
Q4
$79.5M Sell
653,500
-18,800
-3% -$2.1M 0.06% 300
2023
Q3
$75.4M Sell
672,300
-85,400
-11% -$10.8M 0.06% 297
2023
Q2
$110M Sell
757,700
-75,200
-9% -$10.2M 0.07% 257
2023
Q1
$108M Sell
832,900
-19,900
-2% -$2.5M 0.07% 272
2022
Q4
$109M Sell
852,800
-55,565
-6% -$6.45M 0.08% 263
2022
Q3
$95M Buy
908,365
+2,300
+0.3% +$252K 0.07% 280
2022
Q2
$95.2M Sell
906,065
-3,400
-0.4% -$403K 0.06% 292
2022
Q1
$116M Buy
909,465
+91,887
+11% +$11.1M 0.07% 284
2021
Q4
$101M Sell
817,578
-31,930
-4% -$4.18M 0.06% 302
2021
Q3
$121M Sell
849,508
-23,999
-3% -$3.53M 0.08% 249
2021
Q2
$136M Buy
873,507
+52,569
+6% +$8.52M 0.08% 231
2021
Q1
$128M Buy
820,938
+15,038
+2% +$2.33M 0.09% 238
2020
Q4
$121M Sell
805,900
-23,175
-3% -$3.27M 0.09% 229
2020
Q3
$110M Sell
829,075
-11,845
-1% -$1.55M 0.09% 218
2020
Q2
$97.4M Buy
840,920
+18,643
+2% +$2.15M 0.08% 240
2020
Q1
$80.7M Buy
822,277
+155,427
+23% +$20.4M 0.09% 229
2019
Q4
$96.9M Sell
666,850
-29,767
-4% -$4.11M 0.1% 206
2019
Q3
$92.8M Buy
696,617
+10,209
+1% +$1.32M 0.1% 221
2019
Q2
$78.5M Sell
686,408
-14,935
-2% -$1.75M 0.08% 251
2019
Q1
$87M Buy
701,343
+19,982
+3% +$2.27M 0.1% 213
2018
Q4
$68.6M Buy
681,361
+12,978
+2% +$1.46M 0.09% 238
2018
Q3
$85.3M Sell
668,383
-21,527
-3% -$2.56M 0.1% 219
2018
Q2
$74.6M Buy
689,910
+20,806
+3% +$2.26M 0.09% 247
2018
Q1
$70.8M Sell
669,104
-97,644
-13% -$11.3M 0.09% 248
2017
Q4
$89.8M Buy
766,748
+1,030
+0.1% +$116K 0.1% 221
2017
Q3
$87M Buy
765,718
+12,463
+2% +$1.44M 0.1% 219
2017
Q2
$93.9M Buy
753,255
+22,248
+3% +$2.64M 0.11% 201
2017
Q1
$86.7M Buy
731,007
+157,281
+27% +$17.8M 0.11% 212
2016
Q4
$57.5M Buy
573,726
+3,605
+0.6% +$386K 0.09% 246
2016
Q3
$72M Sell
570,121
-6,283
-1% -$776K 0.12% 198
2016
Q2
$67.4M Buy
576,404
+71,070
+14% +$8.04M 0.11% 208
2016
Q1
$50.1M Buy
505,334
+182,001
+56% +$17.6M 0.09% 247
2015
Q4
$32.2M Buy
323,333
+5,253
+2% +$514K 0.08% 274
2015
Q3
$29M Buy
318,080
+35,741
+13% +$3.58M 0.07% 280
2015
Q2
$29.9M Buy
282,339
+16,583
+6% +$1.83M 0.08% 280
2015
Q1
$30.3M Buy
265,756
+103,927
+64% +$11.9M 0.08% 267
2014
Q4
$17.8M Sell
161,829
-4,326
-3% -$456K 0.07% 300
2014
Q3
$16.2M Sell
166,155
-3,811
-2% -$375K 0.06% 312
2014
Q2
$17.1M Sell
169,966
-721
-0.4% -$70.3K 0.06% 306
2014
Q1
$15.7M Sell
170,687
-15,347
-8% -$1.41M 0.06% 306
2013
Q4
$16.8M Sell
186,034
-1,751
-0.9% -$152K 0.07% 300
2013
Q3
$15M Buy
187,785
+2,163
+1% +$170K 0.06% 325
2013
Q2
$13.5M Buy
+185,622
New +$13.9M 0.06% 332

Other funds holding ZBH

Swiss National Bank's ZBH Position: Q2 2026 in Review

Swiss National Bank reduced its Zimmer Biomet (ZBH) stake by 6.1% in Q2 2026, selling an estimated $3.13M and leaving 546,000 shares worth $47M. The position accounts for 0.02% of the portfolio, ranked #462.

Swiss National Bank first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $136M in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Swiss National Bank held 546,000 shares of Zimmer Biomet worth $47M as of Q2 2026.
  • Swiss National Bank sold 35,700 Zimmer Biomet shares in Q2 2026, an estimated $3.13M.
  • Zimmer Biomet made up 0.02% of Swiss National Bank's portfolio in Q2 2026, its #462 holding.
  • Swiss National Bank first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Swiss National Bank's Zimmer Biomet position peaked at $136M in Q2 2021.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.